BCRX logo

BioCryst Pharmaceuticals (BCRX) Retained earnings

annual retained earnings:

-$1.77B-$88.88M(-5.29%)
December 31, 2024

Summary

  • As of today (June 1, 2025), BCRX annual retained earnings is -$1.77 billion, with the most recent change of -$88.88 million (-5.29%) on December 31, 2024.
  • During the last 3 years, BCRX annual retained earnings has fallen by -$562.54 million (-46.59%).
  • BCRX annual retained earnings is now -8132.74% below its all-time high of -$21.50 million, reached on December 31, 1994.

Performance

BCRX Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

quarterly retained earnings:

-$1.77B$32.00K(0.00%)
March 31, 2025

Summary

  • As of today (June 1, 2025), BCRX quarterly retained earnings is -$1.77 billion, with the most recent change of +$32.00 thousand (0.00%) on March 31, 2025.
  • Over the past year, BCRX quarterly retained earnings has dropped by -$53.47 million (-3.11%).
  • BCRX quarterly retained earnings is now -10893.84% below its all-time high of -$16.10 million, reached on March 31, 1994.

Performance

BCRX quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

BCRX Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-5.3%-3.1%
3 y3 years-46.6%-38.1%
5 y5 years-110.6%-101.5%

BCRX Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-46.6%at low-38.1%at low
5 y5-year-110.6%at low-101.5%at low
alltimeall time-8132.7%at low<-9999.0%at low

BCRX Retained earnings History

DateAnnualQuarterly
Mar 2025
-
-$1.77B(-0.0%)
Dec 2024
-$1.77B(+5.3%)
-$1.77B(+1.5%)
Sep 2024
-
-$1.74B(+0.8%)
Jun 2024
-
-$1.73B(+0.7%)
Mar 2024
-
-$1.72B(+2.1%)
Dec 2023
-$1.68B(+15.6%)
-$1.68B(+3.8%)
Sep 2023
-
-$1.62B(+2.3%)
Jun 2023
-
-$1.58B(+5.0%)
Mar 2023
-
-$1.51B(+3.7%)
Dec 2022
-$1.45B(+20.5%)
-$1.45B(+5.2%)
Sep 2022
-
-$1.38B(+3.2%)
Jun 2022
-
-$1.34B(+4.6%)
Mar 2022
-
-$1.28B(+6.1%)
Dec 2021
-$1.21B(+18.0%)
-$1.21B(+1.5%)
Sep 2021
-
-$1.19B(+5.2%)
Jun 2021
-
-$1.13B(+4.0%)
Mar 2021
-
-$1.09B(+6.3%)
Dec 2020
-$1.02B(+21.7%)
-$1.02B(+6.3%)
Sep 2020
-
-$962.95M(+5.0%)
Jun 2020
-
-$916.83M(+4.4%)
Mar 2020
-
-$878.23M(+4.5%)
Dec 2019
-$840.63M(+14.8%)
-$840.63M(+0.3%)
Sep 2019
-
-$838.01M(+4.7%)
Jun 2019
-
-$800.41M(+4.9%)
Mar 2019
-
-$762.78M(+4.2%)
Dec 2018
-$731.97M(+15.8%)
-$731.97M(+3.9%)
Sep 2018
-
-$704.54M(+4.4%)
Jun 2018
-
-$674.94M(+2.8%)
Mar 2018
-
-$656.49M(+3.9%)
Dec 2017
-$631.84M(+11.6%)
-$631.84M(+3.2%)
Sep 2017
-
-$612.30M(+2.5%)
Jun 2017
-
-$597.17M(+2.9%)
Mar 2017
-
-$580.28M(+2.5%)
Dec 2016
-$566.06M(+10.8%)
-$566.06M(+0.8%)
Sep 2016
-
-$561.56M(+2.1%)
Jun 2016
-
-$550.03M(+3.1%)
Mar 2016
-
-$533.75M(+4.5%)
Dec 2015
-$510.92M(+9.2%)
-$510.92M(+3.7%)
Sep 2015
-
-$492.78M(+3.1%)
Jun 2015
-
-$478.16M(-1.0%)
Mar 2015
-
-$483.06M(+3.2%)
Dec 2014
-$467.90M(+10.7%)
-$467.90M(+2.6%)
Sep 2014
-
-$456.23M(+2.0%)
Jun 2014
-
-$447.50M(+3.4%)
Mar 2014
-
-$432.85M(+2.4%)
Dec 2013
-$422.71M(+7.7%)
-$422.71M(+1.3%)
Sep 2013
-
-$417.28M(+2.0%)
Jun 2013
-
-$409.28M(+3.1%)
Mar 2013
-
-$397.11M(+1.1%)
Dec 2012
-$392.60M(+11.1%)
-$392.60M(+2.9%)
Sep 2012
-
-$381.55M(+2.6%)
Jun 2012
-
-$371.85M(+3.4%)
Mar 2012
-
-$359.57M(+1.7%)
Dec 2011
-$353.52M(+19.2%)
-$353.52M(+3.9%)
Sep 2011
-
-$340.33M(+4.4%)
Jun 2011
-
-$325.87M(+5.3%)
Mar 2011
-
-$309.60M(+4.4%)
Dec 2010
-$296.57M(+12.9%)
-$296.57M(+3.6%)
Sep 2010
-
-$286.37M(+3.9%)
Jun 2010
-
-$275.51M(+3.8%)
Mar 2010
-
-$265.31M(+1.0%)
Dec 2009
-$262.72M
-$262.72M(-5.5%)
DateAnnualQuarterly
Sep 2009
-
-$277.87M(+4.0%)
Jun 2009
-
-$267.24M(+3.4%)
Mar 2009
-
-$258.56M(+3.7%)
Dec 2008
-$249.27M(+11.0%)
-$249.27M(-3.9%)
Sep 2008
-
-$259.34M(+3.6%)
Jun 2008
-
-$250.34M(+5.3%)
Mar 2008
-
-$237.63M(+5.8%)
Dec 2007
-$224.54M(+14.9%)
-$224.54M(+1.0%)
Sep 2007
-
-$222.25M(+5.2%)
Jun 2007
-
-$211.27M(+3.4%)
Mar 2007
-
-$204.31M(+4.5%)
Dec 2006
-$195.48M(+28.7%)
-$195.48M(+5.4%)
Sep 2006
-
-$185.43M(+9.2%)
Jun 2006
-
-$169.83M(+6.3%)
Mar 2006
-
-$159.75M(+5.2%)
Dec 2005
-$151.86M(+20.8%)
-$151.86M(+4.9%)
Sep 2005
-
-$144.70M(+5.6%)
Jun 2005
-
-$137.06M(+4.3%)
Mar 2005
-
-$131.41M(+4.5%)
Dec 2004
-$125.76M(+20.2%)
-$125.76M(+4.4%)
Sep 2004
-
-$120.47M(+4.6%)
Jun 2004
-
-$115.18M(+4.6%)
Mar 2004
-
-$110.12M(+5.2%)
Dec 2003
-$104.66M(+13.8%)
-$104.66M(+3.2%)
Sep 2003
-
-$101.41M(+3.5%)
Jun 2003
-
-$98.00M(+3.4%)
Mar 2003
-
-$94.75M(+3.0%)
Dec 2002
-$91.96M(+22.6%)
-$91.96M(+3.1%)
Sep 2002
-
-$89.22M(+4.0%)
Jun 2002
-
-$85.81M(+6.4%)
Mar 2002
-
-$80.65M(+7.5%)
Dec 2001
-$75.03M(+7.1%)
-$75.03M(+7.1%)
Sep 2001
-
-$70.05M(-0.6%)
Jun 2001
-
-$70.47M(-1.3%)
Mar 2001
-
-$71.43M(+2.0%)
Dec 2000
-$70.05M(+19.7%)
-$70.05M(+16.3%)
Sep 2000
-
-$60.25M(+2.8%)
Jun 2000
-
-$58.60M(+3.5%)
Mar 2000
-
-$56.61M(-3.2%)
Dec 1999
-$58.50M(+10.0%)
-$58.50M(+0.9%)
Sep 1999
-
-$58.00M(+3.9%)
Jun 1999
-
-$55.80M(+0.4%)
Mar 1999
-
-$55.60M(+4.5%)
Dec 1998
-$53.20M(+9.9%)
-$53.20M(+2.9%)
Sep 1998
-
-$51.70M(-5.0%)
Jun 1998
-
-$54.40M(+5.8%)
Mar 1998
-
-$51.40M(+6.2%)
Dec 1997
-$48.40M(+28.0%)
-$48.40M(+6.4%)
Sep 1997
-
-$45.50M(+5.8%)
Jun 1997
-
-$43.00M(+5.1%)
Mar 1997
-
-$40.90M(+8.2%)
Dec 1996
-$37.80M(+25.6%)
-$37.80M(+5.9%)
Sep 1996
-
-$35.70M(+7.9%)
Jun 1996
-
-$33.10M(+3.4%)
Mar 1996
-
-$32.00M(+6.3%)
Dec 1995
-$30.10M(+40.0%)
-$30.10M(+7.9%)
Sep 1995
-
-$27.90M(+7.3%)
Jun 1995
-
-$26.00M(+6.6%)
Mar 1995
-
-$24.40M(+13.5%)
Dec 1994
-$21.50M
-$21.50M(+9.7%)
Sep 1994
-
-$19.60M(+8.9%)
Jun 1994
-
-$18.00M(+11.8%)
Mar 1994
-
-$16.10M

FAQ

  • What is BioCryst Pharmaceuticals annual retained earnings?
  • What is the all time high annual retained earnings for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals annual retained earnings year-on-year change?
  • What is BioCryst Pharmaceuticals quarterly retained earnings?
  • What is the all time high quarterly retained earnings for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals quarterly retained earnings year-on-year change?

What is BioCryst Pharmaceuticals annual retained earnings?

The current annual retained earnings of BCRX is -$1.77B

What is the all time high annual retained earnings for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high annual retained earnings is -$21.50M

What is BioCryst Pharmaceuticals annual retained earnings year-on-year change?

Over the past year, BCRX annual retained earnings has changed by -$88.88M (-5.29%)

What is BioCryst Pharmaceuticals quarterly retained earnings?

The current quarterly retained earnings of BCRX is -$1.77B

What is the all time high quarterly retained earnings for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high quarterly retained earnings is -$16.10M

What is BioCryst Pharmaceuticals quarterly retained earnings year-on-year change?

Over the past year, BCRX quarterly retained earnings has changed by -$53.47M (-3.11%)
On this page